Targeted diazeniumdiolates: Localized nitric oxide release from glioma-specific peptides and proteins

International Journal of Pharmaceutics

Volumn 422, Issue 1-2, 2012, Pages 264-270

  Safdar, Shahana ^a   Taite, Lakeshia J ^a  

^a Georgia Institute of Technology   (United States)

Author keywords

Diazeniumdiolate; Glioma; Nitric oxide; Targeted drug delivery

Indexed keywords

CHLOROTOXIN; DIAZENIUMDIOLATE; FLUORESCEIN ISOTHIOCYANATE; NITRIC OXIDE; NITRIC OXIDE DONOR; TOXIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CANCER CONTROL; CELL VIABILITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SPECIFICITY; DRUG SYNTHESIS; DRUG TARGETING; GLIOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL;

ANTINEOPLASTIC AGENTS; AZO COMPOUNDS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; ENDOTHELIAL CELLS; GLIOMA; HUMANS; NITRIC OXIDE; NITRIC OXIDE DONORS; OLIGOPEPTIDES; SCORPION VENOMS; TECHNOLOGY, PHARMACEUTICAL; TIME FACTORS;

EID: 84655162781     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.11.008     Document Type: Article

References (42)

1. J.B. Alavi, and S.L. Eck Gene therapy for high grade gliomas Expert Opin. Biol. Ther. 1 2001 239 252 (Pubitemid 33770080)
2. S. Benedetti, B. Pirola, B. Pollo, L. Magrassi, M.G. Bruzzone, D. Rigamonti, R. Galli, S. Selleri, F. Di Meco, C. De Fraja, A. Vescovi, E. Cattaneo, and G. Finocchiaro Gene therapy of experimental brain tumors using neural progenitor cells Nat. Med. 6 2000 447 450 (Pubitemid 30208163)
3. K.S. Bohl, and J.L. West Nitric oxide-generating polymers reduce platelet adhesion and smooth muscle cell proliferation Biomaterials 21 2000 2273 2278
4. S. Conroy, V. Omid, G. Jonathan, F. Chen, H. Stacey, L. Donghoon, S. Raymond, G.E. Richard, O. Jim, and Z. Miqin In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes Small 4 2008 372 379
5. K.M. Davies, D.A. Wink, J.E. Saavedra, and L.K. Keefer Chemistry of the diazeniumdiolates. 2. Kinetics and mechanism of dissociation to nitric oxide in aqueous solution J. Am. Chem. Soc. 123 2001 5473 5481 (Pubitemid 32888516)
6. J.A. DeBin, J.E. Maggio, and G.R. Strichartz Purification and characterization of chlorotoxin, a chloride channel ligand from the venom of the scorpion Am. J. Physiol. Cell Physiol. 264 1993 C361 C369
7. J. Deshane, C.C. Garner, and H. Sontheimer Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2 J. Biol. Chem. 278 2003 4135 4144 (Pubitemid 36801150)
8. A.S. Dutton, J.M. Fukuto, and K.N. Houk The mechanism of NO formation from the decomposition of dialkylamino diazeniumdiolates: density functional theory and CBS-QB3 predictions Inorg. Chem. 43 2004 1039 1045
9. D. Fukumura, S. Kashiwagi, and R.K. Jain The role of nitric oxide in tumour progression Nat. Rev. Cancer 6 2006 521 534 (Pubitemid 43980541)
10. I. Germano, V. Swiss, and P. Casaccia Primary brain tumors, neural stem cell, and brain tumor cancer cells: where is the link? Neuropharmacology 58 2010 903 910
11. M. Graziewicz, D.A. Wink, and F. Laval Nitric oxide inhibits DNA ligase activity: potential mechanisms for NO-mediated DNA damage Carcinogenesis 17 1996 2501 2505 (Pubitemid 26402253)
12. F.H. Hochberg, and A. Pruitt Assumptions in the radiotherapy of glioblastoma Neurology 30 1980 907 911 (Pubitemid 10059239)
13. J.A. Hrabie, J.R. Klose, D.A. Wink, and L.K. Keefer New nitric oxide-releasing zwitterions derived from polyamines J. Org. Chem. 58 1993 1472 1476
14. J.A. Hrabie, J.E. Saavedra, P.P. Roller, G.J. Southan, and L.K. Keefer Conversion of proteins to diazeniumdiolate-based nitric oxide donors Bioconjug. Chem. 10 1999 838 842 (Pubitemid 29456372)
15. L.J. Ignarro, C. Napoli, and J. Loscalzo Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview Circ. Res. 90 2002 21 28 (Pubitemid 34074604)
16. H.-W. Jun, L.J. Taite, and J.L. West Nitric oxide-producing polyurethanes Biomacromolecules 6 2005 838 844 (Pubitemid 40467826)
17. H. Katsumi, M. Nishikawa, and M. Hashida Development of nitric oxide donors for the treatment of cardiovascular diseases Cardiovascular & Hematological Agents in Medicinal Chemistry 2007 Bentham Science Publishers Ltd. pp. 204-208
18. L.K. Keefer, R.W. Nims, K.M. Davies, and D.A. Wink "NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms P. Lester, Methods in Enzymology 1996 Academic Press 281 293 (Pubitemid 26286370)
19. M. Kurimoto, S. Endo, Y. Hirashima, H. Hamada, T. Ogiichi, and A. Takaku Growth inhibition and radiosensitization of cultured glioma cells by nitric oxide generating agents J. Neurooncol. 42 1999 35 44 (Pubitemid 29216788)
20. D. Lam-Himlin, M.G. Espey, G. Perry, M.A. Smith, and R.J. Castellani Malignant glioma progression and nitric oxide Neurochem. Int. 49 2006 764 768 (Pubitemid 44648494)
21. M.R. Miller, and I.L. Megson Recent developments in nitric oxide donor drugs Br. J. Pharmacol. 151 2007 305 321 (Pubitemid 46842668)
22. S. Moore Amino acid analysis: aqueous dimethyl sulfoxide as solvent for the ninhydrin reaction J. Biol. Chem. 243 1968 6281 6283
23. M.N. Muscara, and J.L.V. Wallace Therapeutic potential of nitric oxide donors and inhibitors Am. J. Physiol. Gastrointest. Liver Physiol. 276 1999 G1313 G1316
24. M. Nakada, S. Nakada, T. Demuth, N. Tran, D. Hoelzinger, and M. Berens Molecular targets of glioma invasion Cell. Mol. Life Sci. 64 2007 458 478
25. D.W Parsons, S. Jones, X. Zhang, J. C.-H. Lin, R.J. Leary, P. Angenendt, P. Mankoo, H. Carter, I.-M. Siu, G.L. Gallia, A. Olivi, R. McLendon, B.A. Rasheed, S. Keir, T. Nikolskaya, Y. Nikolsky, D.A. Busam, H. Tekleab, L.A. Diaz, J. Hartigan, D.R. Smith, R.L. Strausberg, S.K.N. Marie, S.M.O. Shinjo, H. Yan, G.J. Riggins, D.D. Bigner, R. Karchin, N. Papadopoulos, G. Parmigiani, B. Vogelstein, V.E. Velculescu, and K.W. Kinzler An integrated genomic analysis of human glioblastoma multiforme Science 321 2008 1807 1812
26. A.K. Patri, J.F. Kukowska-Latallo, and J.J.R. Baker Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex Adv. Drug Deliv. Rev. 57 2005 2203 2214 (Pubitemid 41759393)
27. K.J. Pulkkanen, and S. Yla-Herttuala Gene therapy for malignant glioma: current clinical status Mol. Ther. 12 2005 585 598 (Pubitemid 41350140)
28. H. Robins, S. Chang, N. Butowski, and M. Mehta Therapeutic advances for glioblastoma multiforme: current status and future prospects Curr. Oncol. Rep. 9 2007 66 70 (Pubitemid 46075636)
29. J.E. Saavedra, T.R. Billiar, D.L. Williams, Y.-M. Kim, S.C. Watkins, and L.K. Keefer Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-α- induced apoptosis and toxicity in the liver J. Med. Chem. 40 1997 1947 1954 (Pubitemid 27265970)
30. J. Shinoda, and I.R. Whittle Nitric oxide and glioma: a target for novel therapy? Br. J. Neurosurg. 15 2001 213 220 (Pubitemid 32660955)
31. S. Sathornsumetee, D.A. Reardon, A. Desjardins, J.A. Quinn, J.J. Vredenburgh, and J.N. Rich Molecularly targeted therapy for malignant glioma Cancer 110 2007 13 24
32. L. Soroceanu, Y. Gillespie, M.B. Khazaeli, and H. Sontheimer Use of chlorotoxin for targeting of primary brain tumors Cancer Res. 58 1998 4871 4879 (Pubitemid 28503684)
33. J. Sudimack, and R.J. Lee Targeted drug delivery via the folate receptor Adv. Drug Deliv. Rev. 41 2000 147 162 (Pubitemid 30122955)
34. 2 grouping J. Org. Chem. 60 1995 435 444
35. O. Veiseh, J.W. Gunn, F.M. Kievit, C. Sun, C. Fang, J.S.H. Lee, and M. Zhang Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles Small 5 2009 256 264
36. O. Veiseh, C. Sun, C. Fang, N. Bhattarai, J. Gunn, F. Kievit, K. Du, B. Pullar, D. Lee, R.G. Ellenbogen, J. Olson, and M. Zhang Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier Cancer Res. 69 2009 6200 6207
37. P.G. Wang, M. Xian, X. Tang, X. Wu, Z. Wen, T. Cai, and A.J. Janczuk Nitric oxide donors: chemical activities and biological applications Chem. Rev. 102 2002 1091 1134 (Pubitemid 35377604)
38. A. Weyerbrock, B. Baumer, and A. Papazoglou Growth inhibition and chemosensitization of exogenous nitric oxide released from NONOates in glioma cells in vitro J. Neurosurg. 110 2009 128 136
39. C. Wu, S.L. Lo, J. Boulaire, M.L.W. Hong, H.M. Beh, D.S.Y. Leung, and S. Wang A peptide-based carrier for intracellular delivery of proteins into malignant glial cells in vitro J. Control. Release 130 2008 140 145
40. R. Yamanaka Cell- and peptide-based immunotherapeutic approaches for glioma Trends Mol. Med. 14 2008 228 235
41. D. Yin, X. Wang, B.M. Konda, J.M. Ong, J. Hu, M.R. Sacapano, M.K. Ko, A.J. Espinoza, D.K. Irvin, Y. Shu, and K.L. Black Increase in brain tumor permeability in glioma-bearing rats with nitric oxide donors Clin. Cancer Res. 14 2008 4002 4009
42. X. Zhang Real time and in vivo monitoring of nitric oxide by electrochemical sensors-from dream to reality Front. Biosci. 9 2004 3434 3446